Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-03-01
1990-08-07
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5482632, A61K 3141
Patent
active
049468561
ABSTRACT:
This invention relates to 5-phenyl-3H-1,2,4-triazol-3-ones and to their use as anticonvulsants for treatment of seizure disorders.
REFERENCES:
patent: 3514466 (1970-05-01), Stahle et al.
patent: 4414221 (1983-11-01), Parsons et al.
G. Maffii, et al., Studio Faramacologico di Alcuni Ossadiazoli e Triazoli, Farmaco 13, 629-38 (1958). (Translation Provided).
M. Y. Mhassalkar, et al., Further Studies in Substituted 4H-1,2,4-Triazoles for Possible Hypoglycemic Activity, J. Med. Chem. 14, 1260-3 (1971).
F. P. Miller, et al., FASEB J. 2, A1070, Abstract 4501 (1988).
Kane John M.
Miller Francis P.
Hollrah Glennon H.
Merrell Dow Pharmaceuticals Inc.
Morris Patricia L.
Nesbitt Stephen L.
Simmons Edlyn S.
LandOfFree
5-phenyl-3H-1,2,4-triazol-3-ones and their use as anticonvulsant does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-phenyl-3H-1,2,4-triazol-3-ones and their use as anticonvulsant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-phenyl-3H-1,2,4-triazol-3-ones and their use as anticonvulsant will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-960884